Aspercreme with Lidocaine Essential Oils Rosemary Mint

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Aspercreme with Lidocaine Essential Oils Rosemary Mint
Generic name
LIDOCAINE
Manufacturer
Chattem, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
9c81d5eb-fa9b-47fb-8924-6ebf6a5c6bab
SPL ID
755e8a1b-8e57-4429-968f-83444bcd5290
Version
4
Effective date
2026-01-13
Source export date
2026-10-22
Source partition
10
Source file
https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-22/cecf96da1d46fddb232fa67374b5f0412041c54b0ff227afc2f842c4c7955161/drug-label-0010-of-0014.json.zip
Source manifest SHA-256
5de9d3c3492926d1703b492ae4d29b036ac5be73edfcb92a6cd5eb95a2acef9c
Import run
20261023T001338Z
Imported at
2026-10-23 01:13:11
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use ■ on large areas of the body or on cut, irritated or swollen skin ■ on puncture wounds ■ for more than one week without consulting a doctor When using this product ■ use only as directed. Read and follow all directions and warnings on this carton. ■ do not allow contact with the eyes and mucous membranes ■ do not bandage or apply local heat (such as heating pads) or a medicated patch to area of use ■ do not use at the same time as other topical analgesics Stop use and ask a doctor if ■ condition worsens ■ redness is present ■ irritation develops ■ symptoms persist for more than 7 days or clear up and occur again within a few days Flammable ■ Keep away from fire or flame If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.